CDC turns to PointClickCare to gain insights from patient data

By Jenni Spinner

- Last updated on GMT

(smartboy10/iStock via Getty Images Plus)
(smartboy10/iStock via Getty Images Plus)

Related tags CDC data analysis Patient outcomes COVID-19 Coronavirus

The US agency plans to use the software firm’s Lighthouse technology to improve understanding of COVID-19 and other conditions in long-term care facilities.

The US Centers for Disease Control and Prevention (CDC) has announced its plans to use technology from cloud-based healthcare software provider PointClickCare to cull insights from COVID-19 and other public health threats. According to the company, the agency will use the firm’s Lighthouse data initiative to gain insights intended to improve the government’s response to the pandemic and other threats to public health.

As part of the collaboration contract, PointClickCare is responsible for providing the CDC de-identified patient data for residents of long-term and post-acute care facilities. The information reportedly data will be employed to address public health priorities, empowering the CDC to analyze disease patterns, progression, and health outcomes; evaluate clinical guidelines uptake, treatments, and interventions; and conduct public health surveillance.

Jason Menges, vice president of national accounts for PointClickCare, said data is an important tool for protecting public health and elevating care.

In today’s increasingly digitally connected world, representative, quality, and timely data are among the most valuable resources for any organization and are exactly what government agencies and research and development teams in both the public and private sector are analyzing to improve care​,” Menges said. “Through this collaboration, CDC will have access to scarcely available data sets that, through analysis, can uncover unique insights into the health of older adults and those who are at greater risk of severe outcomes from COVID-19.​”

According to PointClickCare, the Lighthouse data initiative is intended to gain insights that specifically represent older adults, a patient population at higher risk than most for severe illness, as well as supporting research with expanded drug discovery and development capabilities. PointClickCare reportedly offers access to information of 5m patients across the country.

We’re proud to announce this partnership with CDC and for the opportunity to share our data for the greater good,​” said Jeff Wessinger, vice president and general manager of life sciences with PointClickCare. “CDC’s mission to save lives and protect America from safety, health, and security threats aligns with our goals and values as a company, which are to help improve outcomes for aging and underserved areas of healthcare​.”

Related news

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars